STOCK TITAN

[Form 4] Johnson & Johnson Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Marillyn A. Hewson, a director of Johnson & Johnson (JNJ), acquired 280.788 Deferred Share Units (DSUs) on 09/09/2025 under the company's Amended and Restated Deferred Fee Plan for Directors. The DSUs were recorded at a per-unit value of $178.07 and will be settled in cash upon termination of the reporter's directorship. The reported DSUs include accrued dividend equivalent rights tied to the issuer's quarterly dividend. Following the transaction the reporting person’s total DSU exposure is shown as 13,816.8727 units.

Marillyn A. Hewson, una direttrice di Johnson & Johnson (JNJ), ha acquisito 280.788 Unità Differite di Azioni (DSU) il 09/09/2025 ai sensi del piano di compensi differiti per i membri del consiglio, nella versione modificata e riformulata. Le DSU sono state registrate a un valore per unità di $178,07 e saranno liquidate in contanti al termine della carica di direttore del segnalante. Le DSU riportate includono diritti di equivalenti di dividendi maturi legati al dividendo trimestrale dell’emittente. A seguito della transazione, l’esposizione totale alle DSU del soggetto segnalante è indicata come 13.816,8727 unità.

Marillyn A. Hewson, directora de Johnson & Johnson (JNJ), adquirió 280.788 Unidades Diferidas de Acciones (DSU) el 09/09/2025 conforme al plan de remuneración diferida para Directores, en su versión enmendada y reformada. Las DSU se registraron a un valor por unidad de $178,07 y se liquidarán en efectivo al finalizar el mandato del director reportante. Las DSU reportadas incluyen derechos de equivalentes de dividendo acumulados vinculados al dividendo trimestral de la empresa emisora. Tras la transacción, la exposición total de DSU de la persona reportante se muestra como 13.816,8727 unidades.

Johnson & Johnson(JNJ)의 이사인 Marillyn A. Hewson은 2025년 9월 9일 회사의 개정 및 재정비된 이사용 지연 보수 계획에 따라 280.788 Deferred Share Units(DSU)를 취득했습니다. DSU는 1단위당 값으로 178.07달러로 기록되었으며, 보고자의 이사회직 종료 시 현금으로 settlement될 예정입니다. 보고된 DSU에는 발행사의 분기 배당에 연계된 누적 배당권이 포함되어 있습니다. 거래 이후 보고자의 DSU 총 노출은 13,816.8727단위로 표시됩니다.

Marillyn A. Hewson, administratrice de Johnson & Johnson (JNJ), a acquis 280,788 Unités d’Actions Différées (DAU) le 09/09/2025 dans le cadre du plan de rémunération différée pour les administrateurs, tel que modifié et révisé. Les DAU ont été enregistrées à une valeur par unité de 178,07 $ et seront réglées en espèces lors de la fin du mandat du directeur rapportant. Les DAU déclarées incluent des droits équivalents de dividende accumulés liés au dividende trimestriel de l’émetteur. Suite à la transaction, l’exposition totale en DAU de la personne rapportante est affichée comme 13 816,8727 unités.

Marillyn A. Hewson, Vorstandsmitglied von Johnson & Johnson (JNJ), erwarb am 09.09.2025 280,788 Deferred Share Units (DSUs) gemäß dem geänderten und neu gefassten Deferred Fee Plan for Directors des Unternehmens. Die DSUs wurden mit einem Stückwert von 178,07 $ erfasst und werden bei Beendigung der Direktorenmandats des Meldenden in bar abgewickelt. Die gemeldeten DSUs umfassen aufgelaufene Dividendenequivalent Rights, die an die vierteljährliche Dividende des Emittenten gekoppelt sind. Nach der Transaktion wird die Gesamtexponierung des DSU der meldenden Person als 13.816,8727 Einheiten angezeigt.

ماريلين أ. هيوسن، مديرة في جونسون آند جونسون (JNJ)، اشترت 280.788 وحدة أسهم مؤجلة (DSUs) في 09/09/2025 بموجب الخطة المعدلة والمتجددة للرسوم المؤجلة لمديري الشركة. تم تسجيل DSUs بقيمة وحدة قدرها 178.07 دولار وسيتم تسويتها نقداً عند إنهاء عضويتها كمدير تقارير. تشمل DSUs المقررة حقوقاً مقابل الأرباح مرتبطة بتوزيع الشركة الربعي. بعد إتمام الصفقة، تُظهر أمور الشخص المبلّغ الإجمالي ل DSU بإجمالي 13.816.8727 وحدة.

Marillyn A. Hewson,作为强生公司(JNJ)的董事,按照公司经修订并重述的董事延期酬金计划,于2025年9月9日取得了280.788份延迟股票单位(DSU)。 这些DSU的每单位价值记录为178.07美元,直至报告人退出董事职务时以现金结算。所报告的DSU包含与发行人季度分红相关的累计股息等值权利。交易完成后,该报告人对DSU的总暴露为13,816.8727单位。

Positive
  • Acquisition of 280.788 DSUs demonstrates continued participation in the issuer's director compensation plan
  • DSUs include dividend equivalents, preserving economic parity with shareholders without immediate share issuance
Negative
  • None.

Insights

TL;DR: Routine director compensation deferral; cash-settled DSUs align pay timing with long-term service and reduce share dilution.

The filing documents a standard deferral election under the issuer’s director deferred fee plan. Acquisition of 280.788 DSUs on 09/09/2025 is a non-market transaction coded as an acquisition for deferral of cash retainer. Because DSUs are cash-settled on termination and include dividend equivalents, this conserves outstanding common stock while preserving economic alignment with shareholder returns.

TL;DR: Director converted cash retainer into DSUs valued at $178.07 each; transaction is compensatory rather than open-market trading.

The record shows 280.788 DSUs were acquired at a reported per-unit value of $178.07 and will be paid in cash upon cessation of directorship. Inclusion of dividend equivalents increases the effective economic value of the DSUs. This is a routine, administratively driven transaction and does not represent an equity purchase or sale in the open market.

Marillyn A. Hewson, una direttrice di Johnson & Johnson (JNJ), ha acquisito 280.788 Unità Differite di Azioni (DSU) il 09/09/2025 ai sensi del piano di compensi differiti per i membri del consiglio, nella versione modificata e riformulata. Le DSU sono state registrate a un valore per unità di $178,07 e saranno liquidate in contanti al termine della carica di direttore del segnalante. Le DSU riportate includono diritti di equivalenti di dividendi maturi legati al dividendo trimestrale dell’emittente. A seguito della transazione, l’esposizione totale alle DSU del soggetto segnalante è indicata come 13.816,8727 unità.

Marillyn A. Hewson, directora de Johnson & Johnson (JNJ), adquirió 280.788 Unidades Diferidas de Acciones (DSU) el 09/09/2025 conforme al plan de remuneración diferida para Directores, en su versión enmendada y reformada. Las DSU se registraron a un valor por unidad de $178,07 y se liquidarán en efectivo al finalizar el mandato del director reportante. Las DSU reportadas incluyen derechos de equivalentes de dividendo acumulados vinculados al dividendo trimestral de la empresa emisora. Tras la transacción, la exposición total de DSU de la persona reportante se muestra como 13.816,8727 unidades.

Johnson & Johnson(JNJ)의 이사인 Marillyn A. Hewson은 2025년 9월 9일 회사의 개정 및 재정비된 이사용 지연 보수 계획에 따라 280.788 Deferred Share Units(DSU)를 취득했습니다. DSU는 1단위당 값으로 178.07달러로 기록되었으며, 보고자의 이사회직 종료 시 현금으로 settlement될 예정입니다. 보고된 DSU에는 발행사의 분기 배당에 연계된 누적 배당권이 포함되어 있습니다. 거래 이후 보고자의 DSU 총 노출은 13,816.8727단위로 표시됩니다.

Marillyn A. Hewson, administratrice de Johnson & Johnson (JNJ), a acquis 280,788 Unités d’Actions Différées (DAU) le 09/09/2025 dans le cadre du plan de rémunération différée pour les administrateurs, tel que modifié et révisé. Les DAU ont été enregistrées à une valeur par unité de 178,07 $ et seront réglées en espèces lors de la fin du mandat du directeur rapportant. Les DAU déclarées incluent des droits équivalents de dividende accumulés liés au dividende trimestriel de l’émetteur. Suite à la transaction, l’exposition totale en DAU de la personne rapportante est affichée comme 13 816,8727 unités.

Marillyn A. Hewson, Vorstandsmitglied von Johnson & Johnson (JNJ), erwarb am 09.09.2025 280,788 Deferred Share Units (DSUs) gemäß dem geänderten und neu gefassten Deferred Fee Plan for Directors des Unternehmens. Die DSUs wurden mit einem Stückwert von 178,07 $ erfasst und werden bei Beendigung der Direktorenmandats des Meldenden in bar abgewickelt. Die gemeldeten DSUs umfassen aufgelaufene Dividendenequivalent Rights, die an die vierteljährliche Dividende des Emittenten gekoppelt sind. Nach der Transaktion wird die Gesamtexponierung des DSU der meldenden Person als 13.816,8727 Einheiten angezeigt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HEWSON MARILLYN A

(Last) (First) (Middle)
ONE JOHNSON & JOHNSON PLAZA

(Street)
NEW BRUNSWICK NJ 08933

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Share Units (1) 09/09/2025 A 280.788 (1) (1) Common Stock 280.788 $178.07 13,816.8727(2) D
Explanation of Responses:
1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Remarks:
/s/ Laura H. McFalls, as attorney-in-fact for Marillyn A. Hewson 09/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Marillyn A. Hewson report on Form 4 for JNJ?

The report shows acquisition of 280.788 Deferred Share Units (DSUs) on 09/09/2025 under the company’s deferred fee plan.

What is the reported value per DSU on this Form 4?

The DSUs are reported with a per-unit value of $178.07.

How will the DSUs be settled according to the filing?

The DSUs are cash-settled upon termination of the reporting person’s directorship; each DSU represents the fair market value of one share at settlement.

Does the reported DSU amount include dividend equivalents?

Yes. The filing states the total includes dividend equivalent rights accrued on the DSUs tied to the issuer’s quarterly dividend.

What is the reporter’s total DSU holding following the transaction?

The Form 4 lists 13,816.8727 (units/shares equivalent) as the amount beneficially owned following the reported transaction.
Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Latest SEC Filings

JNJ Stock Data

423.36B
2.41B
0.06%
74.37%
0.78%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NEW BRUNSWICK